A Trial of 18F-AV-133 Positron Emission Tomography (PET)
A Preliminary Evaluation of the Safety and Pancreas Imaging Properties of 18F-AV-133 in Healthy Volunteers and in Patients With Type 1 or Type 2 Diabetes
Sponsor: Avid Radiopharmaceuticals
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Avid Radiopharmaceuticals
Other Type 1 Diabetes trials with similar outcome
This PHASE1 trial investigates Type 1 Diabetes and Type 2 Diabetes and is currently terminated or withdrawn. Avid Radiopharmaceuticals leads this study, which shows 7 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Feb 2020 — Jan 2021 [monthly]
Terminated PHASE1
Status: Suspended → Terminated
-
Jun 2018 — Feb 2020 [monthly]
Suspended PHASE1
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Suspended PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Suspended PHASE1
First recorded
Jun 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Avid Radiopharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .